Key Highlights
- JPMorgan elevated IBM’s rating to Overweight, setting a price target of $291, increased from $270
- Shares climbed over 4% to approximately $263, defying broader market weakness
- IBM’s software division represents roughly 45% of total revenue yet contributes nearly two-thirds of overall profitability
- The Trump administration enacted two executive orders supporting quantum computing advancement, with CEO Arvind Krishna in attendance
- IBM committed $10 billion toward quantum research over a five-year period; second-quarter results scheduled for July 22
Tuesday brought a pair of positive developments for IBM, propelling shares higher despite market headwinds.
International Business Machines Corporation, IBM
Brian Essex, an analyst at JPMorgan, elevated his rating on IBM shares to Overweight from Neutral while increasing his price objective to $291 from $270. The stock surged more than 4% to reach approximately $263.20, even as Nasdaq futures declined 2.66% and S&P 500 futures retreated 1.30%.
Essex’s investment thesis centers on a straightforward premise: IBM’s software segment represents the company’s primary growth engine, and its significance continues to expand. While software comprises approximately 45% of IBM’s total revenue, it generates nearly two-thirds of consolidated profitability. As artificial intelligence adoption accelerates, Essex anticipates this revenue and profit composition will continue tilting toward software.
To accelerate this transformation, IBM has completed approximately 50 acquisitions during the last five years, including the notable March acquisition of Confluent. While some market observers have raised concerns about the acquisition pace, Essex maintains that substantial current investments in software will diminish future capital requirements and progressively transition IBM toward predictable subscription-based revenue streams.
The analyst also highlighted potential valuation expansion opportunities if IBM establishes itself as a significant AI infrastructure provider or advances its quantum computing development schedule.
Presidential Support for Quantum Technology
The analyst upgrade represented just one catalyst behind Tuesday’s gains. On Monday, President Trump enacted two executive orders focused on quantum technology advancement — one establishing a mandate to develop a research-caliber quantum computer by 2028, while another expedites federal adoption of post-quantum cryptographic standards by 2031.
IBM Chief Executive Arvind Krishna participated in the Oval Office signing ceremony. Trump subsequently expressed regret about divesting his IBM holdings prematurely. Such high-profile presidential recognition carries meaningful symbolic value.
Earlier this year, IBM and the Commerce Department jointly announced a $1 billion commitment to construct Anderon, an independent quantum manufacturing facility. IBM subsequently expanded this commitment with an additional $10 billion dedicated to quantum research and production capabilities over five years.
Essex highlighted that IBM has already secured more than $1.1 billion in quantum-related customer agreements since 2017 and has surpassed $1 billion in cumulative quantum revenue. He believes IBM maintains strong positioning within what he characterizes as a substantial total addressable market for quantum technologies.
IBM’s internal objective targets delivery of Starling, its most advanced quantum system, by 2029. Essex indicated that any acceleration of this development timeline “could result in upside” for the stock.
Wall Street Consensus
IBM has attracted increasingly optimistic analyst assessments. Barclays launched coverage earlier this month with a Buy recommendation and $350 price objective, while Citigroup maintains a Buy rating alongside a $375 target. Wedbush assigns an Outperform rating with a $320 price target.
On Monday, IBM disclosed its participation in OpenAI’s Daybreak Cyber Partner Program and unveiled a new AI-enhanced application security platform designed to help enterprises identify and remediate software vulnerabilities more efficiently.
The platform leverages OpenAI’s technology to analyze code, rank high-severity vulnerabilities, and map exploitable attack vectors. This initiative expands Project Lightwell, IBM’s $5 billion collaboration with Red Hat concentrated on software supply chain protection.
IBM will announce second-quarter financial results on July 22. Analysts forecast earnings per share of $3.00, representing growth from $2.80 in the year-ago period, alongside revenue of $17.85 billion compared with $16.98 billion in the corresponding prior-year quarter.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
